Stock Market Today: S&P 500 and Nasdaq Push Higher as Dow Slides on UnitedHealth Plunge and Gold Stays Above $5,000

Stock Market Today: AI Momentum Versus Health-Care Shock

Index Overview: S&P 500 Targets 7,000 While the Dow Is Dragged by UNH

Futures price a split open. S&P 500 futures (ES=F) trade near 6,995, up about 0.2%–0.3%, keeping the index within touching distance of the psychological 7,000 level after Monday’s close around 6,950. Nasdaq 100 futures (NQ=F) add roughly 0.6%–0.7%, driven by renewed appetite for mega-cap tech and AI. Dow futures (YM=F) move the other way, down about 0.7% around 49,200, with UnitedHealth (UNH) alone set to erase ~350–360 Dow points after a double-hit from weak guidance and a punitive Medicare proposal. The volatility backdrop stays benign: the VIX sits near 16, while the 10-year Treasury yield hovers around 4.22% and the 2-year just below 3.60%, signaling no immediate stress in rates even as markets wait for the Fed’s first 2026 decision. The dollar is under pressure, with a broad dollar index in the mid-90s–high-90s zone, reflecting capital moving out of the US currency toward gold, silver, and non-US risk assets.

Mega-Cap Tech and AI: Big Earnings Week Keeps Nasdaq in the Lead

The equity narrative is again dominated by the “earnings plus AI” axis. Four of the “Magnificent Seven” report this week: Tesla (TSLA), Meta Platforms (META), Microsoft (MSFT) and Apple (AAPL), collectively representing roughly 20% of SPX weight. The S&P 500 trades around 22x forward earnings, far above its long-term average of about 15.9x, so any slip in Big Tech delivery will hit index-level valuation, not just the individual stocks. Yet price action says investors still trust the earnings engine. MSFT, META, and AAPL are all indicated higher by around 1%–3% into the open, while TSLA is more volatile after recent weakness but remains a major swing factor for the Nasdaq Composite. ETF flows into AI-heavy products and the Roundhill Magnificent Seven ETF (MAGS) underline how concentrated the US bull market remains in a small group of AI leaders. At the same time, long-only managers are reluctant to underweight the space when the same ~40-odd AI names have contributed well over half of the S&P’s earnings, capex and performance since the generative-AI cycle started. The risk is obvious: if any of MSFT, META, NVDA, AAPL or TSLA cracks on guidance, index-level downside accelerates very fast. But into this week, positioning still assumes they outperform again.

Semiconductors and Infrastructure: MU, INTC, NVDA, CRWV, NET Anchor Risk Appetite

Chip and AI-infrastructure names are doing the heavy lifting for risk sentiment. Micron Technology (MU) trades up about 4% in premarket after announcing a $24 billion NAND memory expansion in Singapore over the next decade, targeting structural shortages in AI-driven memory demand and highlighting confidence that pricing power will remain with suppliers into at least 2027. Intel (INTC), down almost 10% over the last five days after underwhelming guidance, is bouncing about 3% premarket as buyers step in on a “too cheap versus assets and capex” thesis, not on momentum. Nvidia (NVDA) remains the gravitational center: beyond GPU dominance, its $2 billion equity investment in CoreWeave (CRWV) is meant to accelerate the build-out of roughly 5 gigawatts of “AI factories” by 2030, deepening NVDA’s ecosystem lock-in. CoreWeave shares jump roughly 5%–6% on that capital and validation. On the software-infrastructure side, Cloudflare (NET) adds another double-digit premarket gain after a 9% move the previous session, riding expectations that its new AI assistant “Clawdbot” will materially increase high-margin usage of its network. Salesforce (CRM) edges higher by about 2% on a $5.6 billion, 10-year US Army contract, which reinforces the idea that AI/CRM platforms will be embedded in government and defense workflows for a decade. Net effect: semis and AI infrastructure remain the clear leadership pocket; the sector is expensive, but flows and news support a bullish, buy-on-dips stance as long as earnings confirm the capex story.

Health-Care Shock: UNH, HUM, CVS, MOH and the Medicare Advantage Reset

The most violent move on the board comes from managed care. The Centers for Medicare & Medicaid Services (CMS) proposed a 2027 Medicare Advantage rate increase of just 0.09%, versus Wall Street expectations closer to 4%–6%. That is effectively flat nominal funding for a product facing rising medical costs, and it forces a rapid repricing of margins, growth, and valuation across the sector. UnitedHealth (UNH) closed near $351.64 and is trading around $294 premarket, down roughly 16%, after combining that policy blow with a softer 2026 outlook. UNH delivered Q4 EPS of about $2.11, in line with estimates, but down ~70% year-on-year, on quarterly revenue near $113.2 billion versus about $113.7 billion expected and full-year revenue of $447.6 billion (still +12% YoY but a touch under consensus). Management guided 2026 revenue to above $439 billion, implying a ~2% decline, citing enterprise “right-sizing” and a $799 million hit from the 2024 Change Healthcare cyberattack. The medical care ratio (MCR) printed at 89.1% for 2025, with guidance of 88.8% ±50 bps for 2026 – tight enough that any reimbursement squeeze or utilization shock bites directly into EPS. Humana (HUM), heavily exposed to Medicare Advantage, is down around 16% premarket to ~€219–220 after closing near $263.63, while CVS Health (CVS) slides over 10% premarket from around $83.87 toward the mid-$70s. Molina Healthcare (MOH) and Elevance are also under pressure. For index construction, the key is that this is not a blanket health-care selloff. This is a targeted de-rating of one business model: policy-sensitive managed care.

Hospitals, Providers and Intra-Sector Rotation: HCA and the Other Side of the Trade

The other side of that regulatory shock is visible in hospital and provider names. HCA Healthcare (HCA) spiked close to 8% on strong results and guidance that highlight resilient procedure volumes and pricing. Hospitals deliver care and get paid per service; insurers absorb premium risk and policy shifts. A flat Medicare Advantage rate path for 2027 directly compresses insurer economics but does not automatically cut hospital revenue, especially when demand is stable and payer mix can be managed. As managed-care names gap lower on forced selling and risk-off de-leveraging, parts of the health-care complex associated with utilization – hospitals, some device makers, select services – attract rotation capital. This is a textbook rotation within a sector, not an exit from health care. For an active allocator, that means the trade is avoid/underweight the managed-care complex (UNH, HUM, CVS in this context = “hold or reduce”, not “buy the dip”) while selectively adding exposure on strength in providers where fundamentals are improving rather than being repriced by Washington.

Industrial and Transport Standouts: GM, UPS, BA, AAL

Cyclicals are quietly rebuilding leadership. General Motors (GM), now trading around the low-mid $80s, is up roughly 5%–6% premarket after a strong Q4 and aggressive capital return. GM printed Q4 adjusted EPS of $2.51 vs about $2.20 expected, on revenue of $45.29 billion (slightly below the ~$45.8 billion consensus and down 5.1% year-over-year). The company offset the small top-line miss with profitability and a shareholder-friendly package: a 20% dividend increase and a $6 billion buyback. For 2026, GM guides adjusted EBIT to $13–15 billion, automotive free cash flow of $9–11 billion, and adjusted EPS of $11–13. With the stock under 8x the midpoint EPS guide and North American EBIT margins targeted back in the 8%–10% range, the equity screens as cyclical value with capital-return momentum – fundamentally a Buy on this setup.
In transportation, United Parcel Service (UPS) outlines a shift away from low-margin volume. Revenue for last year was about $88.7 billion, and the company now expects 2026 revenue of roughly $89.7 billion, with mix moving toward higher-yielding shipments as the “Amazon glide-down” completes. The stock is up roughly 4% premarket, reflecting confidence that margins can expand even if top-line growth is modest. American Airlines (AAL) posted Q4 EPS of $0.15, missing the $0.30 consensus, but revenue hit a record $14 billion, in line with expectations. Management quantified about $325 million of Q4 revenue lost to the government shutdown and guided 2026 revenue growth of 7%–10%, with full-year adjusted EPS in the $1.70–2.70 range, midpoint above the roughly $1.85 street view. The stock trades around $14.5–15, up about 3%–4% premarket; this is a high-beta cyclical Hold/Speculative Buy, sensitive to macro and fuel but with operating leverage if travel demand stays firm.
Boeing (BA) reported Q4 revenue of $23.95 billion, ahead of the $22.6 billion estimate, and highlighted a commercial backlog above 6,100 aircraft with an implied value around $567 billion. The stock is modestly firmer, reflecting progress on execution rather than a clean balance sheet. Given the litigation, regulatory and execution overhangs, BA remains a Hold with elevated risk, not yet a clean cyclical.

Small-Caps, Value and the 2026 Style Shift

Beyond individual names, style is changing. Veteran strategists flag that small-cap and value stocks are meaningfully outperforming in 2026, marking one of the strongest relative runs for value since the growth-led bull market began. That fits the tape: cyclicals such as GM, industrials, and parts of financials are heating up, while over-owned defensives (managed care) are being de-rated. If the 10-year yield stays below 5%, the value trade can coexist with high-multiple growth. Should yields lurch higher toward or above that 5% threshold, compression risk for long-duration profit stories in tech and AI would rise. Right now, the rate backdrop remains supportive for a barbell: quality Big Tech plus select value cyclicals.

Gold, Silver and the Fear Trade: GC=F, SI=F Above Historic Levels

Precious metals sit just under record highs and remain a core macro story. Gold futures (GC=F) trade slightly negative on the day around $5,040–5,055/oz, but the metal is still above $5,000 for a second session after breaking that level for the first time. Gold has more than doubled in two years and is up roughly 17% year-to-date, driven by reserve diversification, central-bank buying, and investors abandoning sovereign bonds and fiat currencies as fiscal risks mount. A large Japanese bond selloff and fear of fiscal stress in the US are pushing more capital into bullion. Silver (SI=F), trading near $109/oz, is off about 5% today after a 14% one-day spike above $115, its biggest move in over 40 years. Volatility in the iShares Silver Trust (SLV) and similar ETFs shows speculative flows in full force. Strategists at major houses are now comfortable floating targets like $6,000/oz for gold if the dollar weakens further and the “debasement” narrative persists. In equity terms, miners such as Freeport-McMoRan (FCX) and Newmont (NEM) already saw strong gains into this move and will remain extremely sensitive to any pullback in bullion. At current levels, the metals complex justifies a core Gold = Hold/Gradual Buy on dips, Silver = high-beta tactical position, not a core holding.

FX and Rates: Yen Strength, Euro Bid, Dollar Soft

The FX market reinforces the risk-rotation story. The Japanese yen (USD/JPY) trades back below 140 at one point and around 153 in other prints, near its strongest levels in months as traders price in potential joint US-Japan interventions to cap speculative pressure. The euro (EUR/USD) sits around 1.19, up about 0.4%, while GBP/USD trades close to 1.37, also higher on the day. The WSJ Dollar Index near 94–97, down roughly 0.4%, highlights broad dollar selling as investors move toward gold, silver, and non-US risk assets. In rates, markets assign almost 0 probability of a Fed cut this week and barely 10%–15% odds for March; futures still discount roughly two 25 bp cuts by year-end 2026. The 10-year at ~4.23% and 2-year just under 3.60% encapsulate a curve that has steepened modestly but not violently. For equities, this combination – weaker dollar, contained long yields, and strong AI earnings expectations – is equity-friendly, especially for exporters and commodity-linked names.

Trade and Geopolitics: Trump’s Tariff Threats, EU–India FTA, Korea and the KOSPI

Policy risk is loud but not yet dominant in pricing. President Donald Trump has threatened to hike tariffs on South Korean autos, pharmaceuticals and lumber to 25% from 15%, citing delays in ratifying the bilateral trade deal. Korean stocks initially sold off; the KOSPI briefly dropped more than 1%, particularly in autos such as Hyundai Motor and Kia Corp on export-cost fears. Then buyers stepped in aggressively. The KOSPI reversed to new records, with sector indices for chips and industrials pushing higher. SK Hynix jumped about 6%, Samsung Electronics around 3%, reflecting expectations that tariffs will either be scaled back or offset by AI-driven chip demand.
At the same time, the EU and India signed what Brussels calls the “mother of all deals” – a free-trade agreement covering roughly 2 billion people. The EU expects annual tariff savings around $4.8 billion, with tariffs eliminated or reduced on 96.6% of EU goods exports to India; India gains lower or zero tariffs on 99.5% of goods exported to the EU over seven years. Tariffs on European cars into India will fall from around 110% to 10%, with a quota up to 250,000 vehicles per year. The Indian rupee (USD/INR) sits near record lows around 91.6 per dollar, but investors expect the deal to support India’s manufacturing and export base over time. The signal for global markets is clear: US tariff volatility is pushing other large blocks to deepen ties and reduce reliance on the US, which structurally supports non-US equities and EM exporters.

Europe and Italy: STOXX 600, UniCredit, Stellantis and Banking Flows

European indices track the global risk-on mood. The STOXX 600 trades around 612–613, up roughly 0.5%, pointing to a constructive open. In Milan, focus is on UniCredit (UCG) and Stellantis (STLAM). UniCredit has built a 26% stake in Commerzbank, positioning for substantial dividend income; estimates suggest €380–438 million of cash inflow in 2026 if the stake rises to the 29.9% ECB cap. Concurrently, UniCredit is advancing its 2024 buyback, having purchased about 1.72 million shares between January 19–23 at an average price just above €70.71. The second tranche is already over 82% complete, leaving the bank with nearly 49.6 million treasury shares, about 3.18% of share capital. The equity story here is capital-return heavy and leverage-disciplined, a Buy/Hold biased toward Buy as long as asset quality stays under control.
Stellantis shows the other side: the European auto market recovered 1.8% in 2025 to about 10.8 million registrations, still well below pre-COVID volumes. Stellantis posted a 15.3% EU market share, down from 16.4% a year earlier, with about 1.66 million registrations, a 4.7% volume decline. Reports that reopening of the Belvidere, Illinois plant has been pushed to June 2028, around seven months later than previous guidance, underline execution risk and union complexity. That mix – slipping share, delayed capacity, cyclical demand – argues for Stellantis as a value-cyclical Hold, not a high-conviction Buy, until EV execution and US operations are clearer.
Italian banking and resolution flows continue in the background: the Interbank Deposit Protection Fund has approved a €750 million recapitalization plan for Banca Progetto, while MPS is considering selling down its Mediobanca stake from 86% to as low as 51%, potentially raising up to €4.8 billion. These moves reinforce the theme of a still-active balance-sheet clean-up and consolidation cycle in Italian banking, supportive for spreads but not a global driver.

Idiosyncratic Movers: FAT, NET, NUE and Other Singles

Outside the mega-caps, single-stock moves highlight where risk is being repriced most aggressively. FAT Brands (FAT), owner of Fatburger, Johnny Rockets and Twin Peaks, filed for Chapter 11 in Texas after failing to make October interest payments on parts of its $1.2 billion securitization stack; funded debt totals around $1.45 billion. The stock collapsed roughly 30%–40% in premarket trade toward $0.27, underscoring the stress in highly leveraged consumer concepts when financing costs stay elevated.
Nucor (NUE) dropped more than 2% after reporting quarterly profit of $378 million or $1.64/share, up from $287 million or $1.22/share a year ago but below elevated expectations for steel margins in a mixed macro backdrop. The move tells you the bar is high for industrial cyclicals: absolute improvement is not enough if it doesn’t clear consensus.
Meanwhile, Cloudflare (NET) continues its momentum with a further 7%–12% premarket jump after Monday’s 9%+ rally, as markets see leverage to AI agents and data traffic. Intel (INTC), as noted, is rebounding after its post-earnings slump, and memory peers like SanDisk (SNDK) are trading higher on worries that South Korean chip supply could be disrupted by tariffs, tightening an already constrained AI memory market.

Macro and Washington: Fed Pause, Shutdown Risk, and the 10-Year Line in the Sand

On the macro side, the Federal Reserve begins a two-day meeting, with markets fully expecting no change from the current 3.5%–3.75% target range for Fed funds. Futures imply minimal odds of a March cut and a base case of two 25 bp cuts by year-end 2026, contingent on inflation drifting down from the current ~2.8% zone without a labor-market break. Some strategists argue there is room for a small rally in Treasuries after the event simply on relief as the risk passes.
Political risk is less visible in prices but rising in commentary. There is talk that the odds of a US government shutdown before January 30 have climbed above 70%, tied to Senate Democrats pushing back on Homeland Security funding after a controversial ICE-related shooting. At the same time, Trump’s tariff rhetoric against Canada, South Korea and the EU is increasingly treated as a background volatility source rather than a core macro driver unless or until actual tariff schedules change. Strategists stress one key line: the 10-year Treasury becomes problematic for equities only if it “decisively breaks above 5%,” which would signal fiscal stress and force a wholesale recalibration of equity valuation. At ~4.2%, that line is still at a distance.

Top-Down Verdict: Indices, Sectors and Direction – Buy, Sell, or Hold?

Putting the tape and data together, the equity market today is not trading on a simple bullish or bearish narrative; it is trading a high-conviction rotation.
For the indices, the setup is:
– S&P 500 (SPX): Breadth has improved (over 60% of names advancing on Monday), AI/Big Tech earnings are still ahead, and futures point to a possible fifth straight gain with a realistic shot at 7,000. Valuation is rich at 22x forward, but the earnings engine is still accelerating. That warrants a core stance of Hold with a bullish tilt – buy on pullbacks rather than chase breakouts.
– Nasdaq / Nasdaq 100 (IXIC / NDX): Directly geared to MSFT, META, NVDA, AAPL, TSLA and the AI infrastructure story. As long as earnings confirm the capex and demand narrative, the index remains a Buy on dips, with awareness that concentration risk is extreme and any major miss will magnify downside.
– Dow Jones (DJIA): Structurally fine, but near-term hostage to UNH and other large, policy-sensitive components. With UNH undergoing a fundamental de-rating, the Dow is a tactical Hold/Underweight versus SPX and NDX until the Medicare Advantage rate path is clearer.
By sector and theme:
– Managed care (UNH, HUM, CVS, MOH): The 0.09% 2027 rate increase is not noise; it hits the core of the business model. Repricing is rational, not purely emotional. Until CMS clarifies and companies adjust products, this complex is Sell/Underweight – avoid catching the falling knife.
– Hospitals/providers (HCA and peers): Earnings strength, policy insulation and rotation flows support the group. After a large one-day spike, new entries need better prices, but structurally this side of health care is a Buy on orderly pullbacks.
– AI and semiconductors (NVDA, MU, INTC, SK Hynix, Samsung, CRWV, NET): Fundamentals (capex, pricing, scarcity) and flows remain aligned. Valuations are stretched, but news – from $24B Micron investments to $2B NVDA-CoreWeave funding – justifies a Bullish Buy-on-dips view, not wholesale de-risking yet.
– Cyclicals (GM, UPS, AAL, industrials, financials): Earnings beats, buybacks, higher dividends, and better EPS visibility support a pro-cyclical rotation. GM screens as Buy, UPS as Buy/Hold with margin-expansion upside, AAL as speculative Hold/Buy for risk-tolerant investors.
– Precious metals (Gold, Silver, miners): Gold above $5,000 with macro support and central-bank flows justifies core Gold = Buy/Hold with staggered entries, Silver remains a trading vehicle, not a long-term anchor at these volatility levels.
The common denominator across all this: capital is not exiting equities; it is re-allocating aggressively between winners and losers. Today’s market rewards precise positioning – long AI, select cyclicals, hospitals, and non-US beneficiaries of new trade flows – while penalizing complacency in crowded defensives like US managed care.

That's TradingNEWS